Virtual Library

Start Your Search

  • WCLC 2013

    15th World Conference on Lung Cancer

    Access to all presentations that occurred during the 15th World Conference on Lung Cancer in Sydney, Australia.

    Presentation Date(s):  
    • October 27 - 30, 2013
    • Total Presentations: 2517

Filter Results:

Show Only Available Presentations

  • +

    P3.13 - Poster Session 3 - SCLC

    • Type: Poster Session
    • Track: Medical Oncology
    • Presentations: 8
    • Coordinates: 10/30/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P3.13-001 - Could Pretreatment PET-CT Standart Uptake Values Have a Role in the Response to Treatment and the Survival in Patients with Small Cell Lung Cancer?

      09:30 - 09:30  |  Author(s): K. Aydin

      • Abstract

      Loading...

    • +

      P3.13-002 - Stereotactic radiosurgery for brain metastases after prophylactic cranial irradiation in limited disease small-cell lung cancer

      09:30 - 09:30  |  Author(s): K. Sunami

      • Abstract

      Loading...

    • +

      P3.13-003 - Survival of patients with small cell lung carcinoma in Taiwan

      09:30 - 09:30  |  Author(s): Z. Lin

      • Abstract

      Loading...

    • +

      P3.13-004 - A multicenter phase II study of belotecan, a new camptothecin analogue, in elderly patients with previously untreated, extensive-stage small cell lung cancer

      09:30 - 09:30  |  Author(s): C.D. Yeo

      • Abstract

      Loading...

    • +

      P3.13-005 - CONVERT - the challenges of opening centres and recruiting patients to an international multi-centre chemo-radiotherapy trial in limited-stage small cell lung cancer

      09:30 - 09:30  |  Author(s): C. Faivre-Finn

      • Abstract

      Loading...

    • +

      P3.13-006 - Docetaxel-Carboplatin (DC) as Second Line Treatment in Patients With Small Cell Lung Cancer (SCLC): A phase II study.

      09:30 - 09:30  |  Author(s): S. Van Riel

      • Abstract

      Loading...

    • +

      P3.13-007 - Pilot trial of an adjuvant pentavalent vaccine for patients with small cell lung cancer (SCLC)

      09:30 - 09:30  |  Author(s): L.M. Krug

      • Abstract

      Loading...

    • +

      P3.13-008 - Long-term Survival of 187 Patients with Small Cell Lung Cancer Based on the AJCC 6th and 7th TNM Edition

      09:30 - 09:30  |  Author(s): Y.M. Sung

      • Abstract

      Loading...

  • +

    P3.14 - Poster Session 3 - Mesothelioma

    • Type: Poster Session
    • Track: Mesothelioma
    • Presentations: 14
    • Coordinates: 10/30/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P3.14-001 - Assessing the role of chemotherapy for solitary fibrous tumors of the pleura in a routine practice setting

      09:30 - 09:30  |  Author(s): O. Bylicki

      • Abstract

      Loading...

    • +

      P3.14-002 - Second Line- Chemotherapy Treatment Options, In Malignant Mesothelioma Tumors, Resistant To Pemetrexed.

      09:30 - 09:30  |  Author(s): K.N. Syrigos

      • Abstract

      Loading...

    • +

      P3.14-003 - Volatile Organic Compounds as diagnostic tool for Malignant Pleural Mesothelioma.

      09:30 - 09:30  |  Author(s): K. Lamote

      • Abstract

      Loading...

    • +

      P3.14-004 - Adjuvant Hemithoracic Radiotherapy After Extrapleural Pneumonectomy For Malignant Pleural Mesothelioma: Experience At The Sydney Cancer Centre

      09:30 - 09:30  |  Author(s): A. Bece

      • Abstract

      Loading...

    • +

      P3.14-005 - Integrating a well living programme into a support group for EPP survivors and carers

      09:30 - 09:30  |  Author(s): J. McLean

      • Abstract

      Loading...

    • +

      P3.14-006 - Radiotherapy for the treatment of pain in Malignant Pleural Mesothelioma: A Systematic Review

      09:30 - 09:30  |  Author(s): N.J. Macleod

      • Abstract

      Loading...

    • +

      P3.14-007 - Chimeric Antibody Receptor (CAR) Augmented Adoptive T Cell Therapy (ACT) for Patients with Progressive Malignant Pleural Mesothelioma (MPM)

      09:30 - 09:30  |  Author(s): E.K. Moon

      • Abstract

      Loading...

    • +

      P3.14-008 - Resection and Heated Pleural Chemoperfusion for Epithelioid Malignant Pleural Mesothelioma; A Single Center Experience

      09:30 - 09:30  |  Author(s): R. Ben Avi

      • Abstract

      Loading...

    • +

      P3.14-009 - High resolution study on survival of pleural mesothelioma from the records of the Piedmont Registry of Malignant Mesotheliomas - report on incident cases 2008-2009

      09:30 - 09:30  |  Author(s): D. Mirabelli

      • Abstract

      Loading...

    • +

      P3.14-010 - Evaluation of Mesothelioma Tumor Thickness Measurement Variability

      09:30 - 09:30  |  Author(s): A.K. Nowak

      • Abstract

      Loading...

    • +

      P3.14-011 - Genomic profiling of Epithelial Malignant Pleural Mesothelioma (MPM) using Massively Parallel Sequencing.

      09:30 - 09:30  |  Author(s): T. Seiwert

      • Abstract

      Loading...

    • +

      P3.14-012 - Pathological complete response after platinum-based chemotherapy in malignant pleural mesothelioma

      09:30 - 09:30  |  Author(s): S.S. Kumar

      • Abstract

      Loading...

    • +

      P3.14-013 - Longitudinal Observation of Health Related Quality of Life following Extrapleural Pneumonectomy for Malignant Pleural Mesothelioma

      09:30 - 09:30  |  Author(s): J.M. Fowler

      • Abstract

      Loading...

    • +

      P3.14-014 - Chemotherapy for mesothelioma: patient, caregiver and health professionals' perceptions of treatment and what influences access.

      09:30 - 09:30  |  Author(s): H.M. Dhillon

      • Abstract

      Loading...

  • +

    P3.15 - Poster Session 3 - Thymoma

    • Type: Poster Session
    • Track: Thymoma & Other Thoracic Malignancies
    • Presentations: 3
    • Coordinates: 10/30/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P3.15-001 - Primary mediastinal tumors: epidemiological analysis of 12-years observations.

      09:30 - 09:30  |  Author(s): M. Szolkowska

      • Abstract

      Loading...

    • +

      P3.15-002 - Can D2-40 antibody help in identifying B2 thymomas? Preliminary observations.

      09:30 - 09:30  |  Author(s): M. Szolkowska

      • Abstract

      Loading...

    • +

      P3.15-003 - Stage and presence of Myasthenia determine the recurrence free survival in thymoma: Single Institute experience

      09:30 - 09:30  |  Author(s): P. Sebastian

      • Abstract

      Loading...

  • +

    P3.16 - Poster Session 3 - Other Thoracic Malignancies

    • Type: Poster Session
    • Track: Thymoma & Other Thoracic Malignancies
    • Presentations: 3
    • Coordinates: 10/30/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P3.16-001 - Late-developing tongue adenoid cystic carcinoma after pulmonary metastasectomy

      09:30 - 09:30  |  Author(s): Y.J. Sa

      • Abstract

      Loading...

    • +

      P3.16-002 - Outcome and prognostic factors of bronchopulmonary neuroendocrine tumors (BNETS): a single intitutional series

      09:30 - 09:30  |  Author(s): C. Verroken

      • Abstract

      Loading...

    • +

      P3.16-003 - Overall Survival and Surgical Outcomes for Mediastinal germ-cell tumors: The National Cancer Institute of Mexico experience.

      09:30 - 09:30  |  Author(s): J.F. Corona-Cruz

      • Abstract

      Loading...

  • +

    P3.17 - Poster Session 3 - Bronchoscopy, Endoscopy

    • Type: Poster Session
    • Track:
    • Presentations: 9
    • Coordinates: 10/30/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P3.17-001 - Assessment of pulmonary hemorrhage by bronchoscopy and CT findings in patients treated with bevacizumab

      09:30 - 09:30  |  Author(s): N. Furuya

      • Abstract

      Loading...

    • +

      P3.17-002 - Virtual Bronchoscopy and Virtual Bronchoscopic Lung Biopsy using OsiriX

      09:30 - 09:30  |  Author(s): A. Sano

      • Abstract

      Loading...

    • +

      P3.17-003 - Implementation of Rapid On-Site Evaluation for Linear EBUS: Local experience from the Austin Hospital, Melbourne

      09:30 - 09:30  |  Author(s): R. Wong

      • Abstract

      Loading...

    • +

      P3.17-004 - Breath-hold low dose CT immediately following PET/CT enables good quality Virtual Bronchoscopy prior to EBUS guide sheath biopsy

      09:30 - 09:30  |  Author(s): D. Fielding

      • Abstract

      Loading...

    • +

      P3.17-005 - Diagnostic Yield of Flexible Bronchoscopy in Evaluating Peripheral Lung Lesions Without Endobronchial Lesions

      09:30 - 09:30  |  Author(s): S.H. Lee

      • Abstract

      Loading...

    • +

      P3.17-006 - Endobronchial Ultrasound Elastography in mediastinal lymph nodes: initial experiences

      09:30 - 09:30  |  Author(s): T. Inoue

      • Abstract

      Loading...

    • +

      P3.17-007 - Rapid On-Site Cytologic Evaluation (ROSE) of bronchial brushings during bronchoscopic investigation of peripheral pulmonary lesions: diagnostic accuracy and impact on procedure time

      09:30 - 09:30  |  Author(s): D.P. Steinfort

      • Abstract

      Loading...

    • +

      P3.17-008 - Electromagnetic Navigation Bronchoscopy increases diagnostic yield after non-diagnostic Endobronchial Ultrasound Guide Sheath for peripheral pulmonary lesions

      09:30 - 09:30  |  Author(s): S. Leong

      • Abstract

      Loading...

    • +

      P3.17-009 - A Prospective Clinical Study of MicroRNA Expression Profiling of Bronchoalveolar Lavage Fluids and Sputum as a Means to Distinguish Early Stage Non-Small Cell Lung Cancer Cases From Cancer-Free Controls

      09:30 - 09:30  |  Author(s): J.O. Kim

      • Abstract

      Loading...

  • +

    P3.18 - Poster Session 3 - Pathology

    • Type: Poster Session
    • Track: Pathology
    • Presentations: 21
    • Coordinates: 10/30/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P3.18-001 - Prognostic value of the IASLC/ATS/ERS classification in stage I lung adenocarcinoma patients

      09:30 - 09:30  |  Author(s): Z. Song

      • Abstract

      Loading...

    • +

      P3.18-002 - Predicting stratification for recurrence of early lung adenocarcinoma based on 7th TNM classification and IASLC/ATS/ERS classification

      09:30 - 09:30  |  Author(s): M. Ito

      • Abstract

      Loading...

    • +

      P3.18-003 - ROS1 Gene Rearrangements in Non-Small Cell Lung Carcinoma - A New Genetic Target that can be Identified by Immunohistochemistry and FISH

      09:30 - 09:30  |  Author(s): W.A. Cooper

      • Abstract

      Loading...

    • +

      P3.18-004 - Pulmonary ossifications: To be considered in the differential diagnosis of solitary pulmonary nodules.

      09:30 - 09:30  |  Author(s): J.F. Gielis

      • Abstract

      Loading...

    • +

      P3.18-005 - EGFR mutation testing methods in clinical practice in Central Europe: findings from the INSIGHT observational study

      09:30 - 09:30  |  Author(s): W. Olszewski

      • Abstract

      Loading...

    • +

      P3.18-006 - Non-terminal respiratory unit lung adenocarcinoma: can have 3 subtypes and is associated with poor prognosis

      09:30 - 09:30  |  Author(s): A. Yoshizawa

      • Abstract

      Loading...

    • +

      P3.18-007 - Metastatic sites with a major component of solid pattern pulmonary adenocarcinoma are associated with shorter survival with systemic therapy and infrequent EGFR mutations

      09:30 - 09:30  |  Author(s): T.D. Clay

      • Abstract

      Loading...

    • +

      P3.18-008 - EGFR Mutation Testing in Saudi Arabian Lung Adenocarcinoma

      09:30 - 09:30  |  Author(s): F.H. Al-Dayel

      • Abstract

      Loading...

    • +

      P3.18-009 - Clinicopathological characteristics of primary lung mucinous adenocarcinoma in surgically resected cases

      09:30 - 09:30  |  Author(s): H. Ichinokawa

      • Abstract

      Loading...

    • +

      P3.18-010 - 5 Driver genes in Chinese Female Lung Adenocarcinoma

      09:30 - 09:30  |  Author(s): B. Han

      • Abstract

      Loading...

    • +

      P3.18-011 - Prognostic value of blood and lymphatic vessels embolism (pV, pL) in early stage lung cancer (IA, IB).

      09:30 - 09:30  |  Author(s): P. Rudzinski

      • Abstract

      Loading...

    • +

      P3.18-012 - The hidden 50% of the ALK positive NSCLC patients

      09:30 - 09:30  |  Author(s): M. Pekar

      • Abstract

      Loading...

    • +

      P3.18-013 - Diffuse idiopathic pulmonary neuroendocrine hyperplasia and pulmonary carcinoid tumors - own experiences

      09:30 - 09:30  |  Author(s): R. Langfort

      • Abstract

      Loading...

    • +

      P3.18-014 - Implementing systematic histological and genotypic re-evaluation of Non Small Cell Lung Cancer (NSCLC) into routine clinical practice: a monocentric study

      09:30 - 09:30  |  Author(s): S. Vatrano

      • Abstract

      Loading...

    • +

      P3.18-015 - The Utility of a Novel Triple Marker (combination of TTF, napsin-A and p40) in the Subclassification of Non-small Cell Lung Cancer (NSCLC).

      09:30 - 09:30  |  Author(s): H. Zhang

      • Abstract

      Loading...

    • +

      P3.18-016 - The usefulness of frozen section diagnosis as for the decision making milestone during the surgery for pulmonary ground glass nodules: embedding medium inflation technique

      09:30 - 09:30  |  Author(s): Y. Hwang

      • Abstract

      Loading...

    • +

      P3.18-017 - Biobanking in Lung research - Quality and technical aspects

      09:30 - 09:30  |  Author(s): M. Lindner

      • Abstract

      Loading...

    • +

      P3.18-018 - Results of upfront genomic testing in non-small cell lung cancer (NSCLC) patients (MSN study)

      09:30 - 09:30  |  Author(s): D. Planchard

      • Abstract

      Loading...

    • +

      P3.18-019 - Profiling of Actionable Alterations in Lung Adenocarcinoma

      09:30 - 09:30  |  Author(s): K. Prabhash

      • Abstract

      Loading...

    • +

      P3.18-020 - The mutational profile of lung adenocarcinoma in Korean population

      09:30 - 09:30  |  Author(s): Y.J. Jung

      • Abstract

      Loading...

    • +

      P3.18-021 - Array CGH is useful in the evaluation of patients with synchronic or metachronic tumors

      09:30 - 09:30  |  Author(s): J.P.L. Vincenten

      • Abstract

      Loading...

  • +

    P3.19 - Poster Session 3 - Imaging

    • Type: Poster Session
    • Track: Imaging, Staging & Screening
    • Presentations: 20
    • Coordinates: 10/30/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P3.19-001 - Correlation between whole tumor size and solid component size on high-resolution computed tomography in the prediction of the degree of pathologic malignancy and the prognostic outcome in primary lung adenocarcinoma

      09:30 - 09:30  |  Author(s): H. Saji

      • Abstract

      Loading...

    • +

      P3.19-002 - Fibrotic changes on low-dose chest CT as a risk factor of lung cancer development in subjects with asbestos exposure

      09:30 - 09:30  |  Author(s): K. Gemba

      • Abstract

      Loading...

    • +

      P3.19-003 - The correlation between computed tomography findings and the clinicopathological factors in small-sized adenocarcinomas of the lung (10 mm or less in diameter)

      09:30 - 09:30  |  Author(s): F. Karino

      • Abstract

      Loading...

    • +

      P3.19-004 - Comparison of objective criteria and expert visual interpretation to classify benign and malignant hilar and mediastinal nodes on 18-F FDG PET/CT.

      09:30 - 09:30  |  Author(s): P. Nguyen

      • Abstract

      Loading...

    • +

      P3.19-005 - Quantitative CT predicts histological tumor invasiveness: analysis on 211 lesions of cT1N0M0 lung adenocarcinoma

      09:30 - 09:30  |  Author(s): K. Shikuma

      • Abstract

      Loading...

    • +

      P3.19-006 - Pseudopathologic Vertebral Body Enhancement in the Presence of Superior Vena Cava Obstruction on Computed Tomography

      09:30 - 09:30  |  Author(s): Y.M. Sung

      • Abstract

      Loading...

    • +

      P3.19-007 - Reliability Analysis of Visual Ranking of Coronary Artery Calcification on Low-Dose CT of the Thorax for Lung Cancer Screening: Comparison with ECG-gated Calcium Scoring CT

      09:30 - 09:30  |  Author(s): Y.M. Sung

      • Abstract

      Loading...

    • +

      P3.19-008 - Positron Emission Tomography Scan in Lung Cancer: New Insights In Tumor Biology?

      09:30 - 09:30  |  Author(s): M.T. Almodovar

      • Abstract

      Loading...

    • +

      P3.19-009 - Newly developed early lung cancer during follow-up of idiopathic interstitial pneumonia: serial HRCT observations

      09:30 - 09:30  |  Author(s): M.Y. Kim

      • Abstract

      Loading...

    • +

      P3.19-010 - The Status of EGFR Mutations in Mixed Ground-Glass Opacity (part-solid GGO) on Thin-section CT

      09:30 - 09:30  |  Author(s): H. Saito

      • Abstract

      Loading...

    • +

      P3.19-011 - The role of 18F-FDG PET/CT and 68Ga-DOTANOC PET/CT in differentiating typical
      and atypical pulmonary carcinoids

      09:30 - 09:30  |  Author(s): F. Lococo

      • Abstract

      Loading...

    • +

      P3.19-012 - Comparison of three models to estimate the probability of malignancy in Chinese patients with solitary pulmonary nodules

      09:30 - 09:30  |  Author(s): X. Zhang

      • Abstract

      Loading...

    • +

      P3.19-013 - The relationship between iodine-related attenuation of dual-energy CT and standardized uptake value of 18FDG PET-CT in patients with non-small cell lung cancer

      09:30 - 09:30  |  Author(s): E.Y. Kim

      • Abstract

      Loading...

    • +

      P3.19-014 - CT Morphologic Patterns, Pathologic Subtypes, and Genetic Phenotypes: A Correlation Study in 600 Nodular Lung Adenocarcinomas

      09:30 - 09:30  |  Author(s): H. Lee

      • Abstract

      Loading...

    • +

      P3.19-015 - Should core biopsy with larger needle replace FNAB in assessing lung masses?

      09:30 - 09:30  |  Author(s): M. Busso

      • Abstract

      Loading...

    • +

      P3.19-016 - Fast Fourier transform analysis for the contour of pulmonary nodules.

      09:30 - 09:30  |  Author(s): M. Kawago

      • Abstract

      Loading...

    • +

      P3.19-017 - 18F-FDG-PET-CT imaging in malignant mesothelioma

      09:30 - 09:30  |  Author(s): N. Mandel

      • Abstract

      Loading...

    • +

      P3.19-018 - Incidental detection on computed tomography is an independant prognostic factor of survival in patients operated for non-small cell lung carcinoma

      09:30 - 09:30  |  Author(s): T. Gudbjartsson

      • Abstract

      Loading...

    • +

      P3.19-019 - Evaluation of Erlotinib treatment response in non-small cell lung cancer using EORTC metabolic criteria, PERCIST and anatomic criteria RECIST

      09:30 - 09:30  |  Author(s): M. Ippolito

      • Abstract

      Loading...

    • +

      P3.19-020 - Multivariable analysis of the high resolution-CT findings of the presence or absence of epidermal growth factor receptor mutation for 476 primary lung adenocarcinomas

      09:30 - 09:30  |  Author(s): M. Ishijima

      • Abstract

      Loading...

  • +

    P3.20 - Poster Session 3 - Early Detection and Screening

    • Type: Poster Session
    • Track: Imaging, Staging & Screening
    • Presentations: 11
    • Coordinates: 10/30/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P3.20-001 - DNA methylation profiling in NSCLC identifies putative diagnostic markers for screening and early detection of lung cancer

      09:30 - 09:30  |  Author(s): A. Iwamaru

      • Abstract

      Loading...

    • +

      P3.20-002 - First low dose chest CT lung cancer screening programs in Poland - overall results

      09:30 - 09:30  |  Author(s): T. Grodzki

      • Abstract

      Loading...

    • +

      P3.20-003 - A Practice Guideline for Low Dose CT Screening for Lung Cancer: Evidence Based Recommendations Before Implementation.

      09:30 - 09:30  |  Author(s): Y.C. Ung

      • Abstract

      Loading...

    • +

      P3.20-004 - Analysis of exhaled breath for screening of lung cancer patients

      09:30 - 09:30  |  Author(s): J. Park

      • Abstract

      Loading...

    • +

      P3.20-005 - Cardiac CT and pulmonary nodules; Incidental findings and incidence of malignancy in an Australian population

      09:30 - 09:30  |  Author(s): J. Robertson

      • Abstract

      Loading...

    • +

      P3.20-006 - Proteomic analysis of the bronchial epithelium to develop a molecular signature of risk for lung cancer

      09:30 - 09:30  |  Author(s): J. Rahman

      • Abstract

      Loading...

    • +

      P3.20-007 - Chest X-ray (CXR) Screening for Lung Cancer: Overdiagnosis, Endpoints, and Randomized Population Trials (RPTs)

      09:30 - 09:30  |  Author(s): G.M. Strauss

      • Abstract

      Loading...

    • +

      P3.20-008 - Prompting earlier diagnosis of lung cancer: evaluation of a public education campaign in NSW to raise awareness of lung cancer symptoms

      09:30 - 09:30  |  Author(s): M. Lafontaine

      • Abstract

      Loading...

    • +

      P3.20-009 - Diagnostic performance of a filter-based antibody-independent peripheral blood circulating tumour cell capture paired with cytomorphologic criteria for the diagnosis of lung cancer

      09:30 - 09:30  |  Author(s): D.V. Freydina

      • Abstract

      Loading...

    • +

      P3.20-010 - Low Dose Computerized Tomography (LDCT) as a Lung Cancer Screening Tool in an Endemic Area of Tuberculosis: A Preliminary Report

      09:30 - 09:30  |  Author(s): N. Triphuridet

      • Abstract

      Loading...

    • +

      P3.20-011 - Lung density versus emphysema as predictor of malignancy risk of pulmonary nodules detected on first screening CT

      09:30 - 09:30  |  Author(s): K. Ohtani

      • Abstract

      Loading...

  • +

    P3.21 - Poster Session 3 - Diagnosis and Staging

    • Type: Poster Session
    • Track: Prevention & Epidemiology
    • Presentations: 12
    • Coordinates: 10/30/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P3.21-001 - Metastatic locations in non-small cell lung cancer and their prognostic significance

      09:30 - 09:30  |  Author(s): R. Diaconescu

      • Abstract

      Loading...

    • +

      P3.21-002 - Lung-EPICLIN: analysis of EGFR mutations and associated clinico-pathological parameters in patients with NSCLC in Russian Federation

      09:30 - 09:30  |  Author(s): S. Tjulandin

      • Abstract

      Loading...

    • +

      P3.21-003 - The LungPath Study: Variation in lung cancer diagnostics in England. Does the availability of PET scanning and EBUS affect patient care?

      09:30 - 09:30  |  Author(s): P. Cane

      • Abstract

      Loading...

    • +

      P3.21-004 - Therapeutic Delay due to Molecular Testing in Patients with Stage IV NSCLC Newly Diagnosed.

      09:30 - 09:30  |  Author(s): J.A. Lacava

      • Abstract

      Loading...

    • +

      P3.21-005 - Clinical characteristics of non-small cell lung cancer with EGFR mutations in never smokers

      09:30 - 09:30  |  Author(s): Y.S. Park

      • Abstract

      Loading...

    • +

      P3.21-006 - The N-classification Based on the Number of Metastatic Lymph Node is Superior to Regional N-classification in Predicting Outcomes After Surgical Resection for Non-small Cell Lung Cancer.

      09:30 - 09:30  |  Author(s): S.Y. Yeom

      • Abstract

      Loading...

    • +

      P3.21-007 - EGFR mutation analysis in sputum of lung cancer patients: a multicenter multitechnique study

      09:30 - 09:30  |  Author(s): A.J. Hubers

      • Abstract

      Loading...

    • +

      P3.21-008 - Effective Diagnosis of Postoperative Mediastinal Recurrence of Lung Cancer by Endobronchial Ultrasound-guided Transbronchial Needle Aspiration

      09:30 - 09:30  |  Author(s): T. Yamamoto

      • Abstract

      Loading...

    • +

      P3.21-009 - Differential diagnosis of intrathoracic lymphadenopathy and/or infiltrates in patients with malignant tumours

      09:30 - 09:30  |  Author(s): R. Bittenglova

      • Abstract

      Loading...

    • +

      P3.21-010 - A retrospective compability assessment of ALK translocation diagnosis in NSCLC

      09:30 - 09:30  |  Author(s): T. Yokoi

      • Abstract

      Loading...

    • +

      P3.21-011 - Proposal of an alternative prognosis prediction method - Hazard Ratio scoring system based on well-suited nomogram.

      09:30 - 09:30  |  Author(s): H. Lee

      • Abstract

      Loading...

    • +

      P3.21-012 - Institutional Experience In Obtained Biopsy In Patients With NSCLC In One Center In Argentina

      09:30 - 09:30  |  Author(s): E.A. Richardet

      • Abstract

      Loading...

  • +

    P3.22 - Poster Session 3 - Epidemiology, Etiology

    • Type: Poster Session
    • Track: Prevention & Epidemiology
    • Presentations: 10
    • Coordinates: 10/30/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P3.22-001 - Incidence of lung cancer and pulmonary emphysema, a study of 708 autopsy cases from University Hospital Motol, Prague

      09:30 - 09:30  |  Author(s): M. Marel

      • Abstract

      Loading...

    • +

      P3.22-002 - Lung Cancer: histology, gender and age changes over the past 25 years in Brazil

      09:30 - 09:30  |  Author(s): M.T. Ruiz-Tsukazan

      • Abstract

      Loading...

    • +

      P3.22-003 - EGFR genotyping and epidemiology, clinical and pathological features in 191 patients with metastatic pulmonary adenocarcinoma in Sao Paulo - Brazil.

      09:30 - 09:30  |  Author(s): G. Castro Jr.

      • Abstract

      Loading...

    • +

      P3.22-004 - Cancer and Tuberculosis, experience in a Chest Hospital

      09:30 - 09:30  |  Author(s): R. Billone

      • Abstract

      Loading...

    • +

      P3.22-005 - XPA gene rs1800975 single nucleotide polymorphism and lung cancer risk: a meta-analysis

      09:30 - 09:30  |  Author(s): Y. Lou

      • Abstract

      Loading...

    • +

      P3.22-006 - Incidence and 5-year survival of lung cancer in Queensland, Australia: an epidemiological study.

      09:30 - 09:30  |  Author(s): E.S. Ahern

      • Abstract

      Loading...

    • +

      P3.22-007 - Determining completeness of case ascertainment to a lung cancer registry:
      A single institutional study.

      09:30 - 09:30  |  Author(s): R. Stirling

      • Abstract

      Loading...

    • +

      P3.22-008 - Are there disparities in lung cancer incidence trends among Hispanics and African Americans? An analysis of the Surveillance Epidemiology and End Results Database 1992-2010

      09:30 - 09:30  |  Author(s): M.I. Patel

      • Abstract

      Loading...

    • +

      P3.22-009 - Lung cancer in women: clinical and pathologic features

      09:30 - 09:30  |  Author(s): M. Tor

      • Abstract

      Loading...

    • +

      P3.22-010 - Advanced Non-Small Cell Lung Cancer (NSCLC-AD) in patients under 50 - a new reality

      09:30 - 09:30  |  Author(s): A.R. Figueredo

      • Abstract

      Loading...